An observational study in Urinary Retention, sponsored by Endeavor Health. Terminated at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-07-24.
Sponsored by Endeavor Health · Observational
This study investigates patient's preference and satisfaction with choice of catheterization after surgical urogynecological procedures.
Preoperatively, the enrolled patient receives information about risks and benefits of three ways of bladder catheterization as means of management of postoperative urinary retention. Based on this information, the patient chooses her preferred way of postoperative catheterization in case she experiences acute urinary retention after surgery. After the surgery, those patients requiring catheterization postoperatively evaluate their experience in a postoperative questionnaire.
240 studies on the registry are indexed under Urinary Retention; 39 are open to participants now.
This study's enrollment of 47 is below the median of 100 across 44 observational studies indexed under Urinary Retention.
Browse Urinary Retention studies →Endeavor Health is the lead sponsor of 111 studies on the registry; 34 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 9 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult women presenting to the urogynecology offices at NorthShore University HealthSystem with a urogynecologic diagnosis desiring surgical management.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patient satisfaction with choice of catheterization method
Assessed through post-operative questionnaire completion
Time frame: 2 weeks after index procedure
Assessment of complication rates
Comparison of complication rates between intermittent vs. indwelling catheterization: data derived from review of participant medical record
Time frame: 2 weeks after index procedure
Ran from Apr 2010 to primary completion in Dec 2014, 56 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.